Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YDR2 | ISIN: US5845071076 | Ticker-Symbol: N/A
1-Jahres-Chart
MEDICAL CARE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
MEDICAL CARE TECHNOLOGIES INC 5-Tage-Chart
ACCESS Newswire
308 Leser
Artikel bewerten:
(2)

Medical Care Technologies Inc. 2026 Annual Shareholder Update and Strategic Roadmap

MESA, AZ / ACCESS Newswire / January 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-focused company developing AI-driven consumer, wellness, and medical applications, today provided its 2026 annual shareholder update outlining its short-term, near-term, and long-term strategic goals as the Company advances its next phase of growth. These updates are also updated on our corporate website www.medicalcaretechnologies.com.

Short-Term Goals (Coming Weeks / Months)

Launch the Company's first completed consumer-based AI mobile application across 127 countries and 30 languages, demonstrating scalability, revenue potential, and global reach.

Establish MDCE's first direct, non-subsidiary revenue stream through consumer AI applications.

Announce the official name and branding of the first consumer app, accompanied by a coordinated launch campaign.

Outline plans for multiple upcoming AI applications across health, wellness, and dietary categories to support near-term revenue generation.

Continue development and testing of AI-based mobile applications addressing consumer and medical needs, including projects currently in prototype stages to be announced at a later date.

Subsidiaries Infinite Auctions and Real Game Used to continue generating revenue through high-value collectible sales and AI-based authentication services, respectively.

Near-Term Goals (2026)

Develop and release one or more medical-grade beta applications.

Conduct structured beta testing in collaboration with Arizona State University medical student groups.

Advance select applications into clinical-grade efficacy testing with patient testing and a follow-up round supervised my medical professionals.

Continue expanding the Company's and other AI platform capabilities to support both consumer and medical use cases.

Long-Term Goals (2027 and Beyond)

Pursue an uplisting to OTCQB, subject to meeting qualification standards, to enhance corporate credibility, transparency, and investor access.

Complete the Company's provisional patent related to its patent-pending AI image analysis process.

Explore clinical and institutional partnerships for medical-focused applications.

Seek clinical validation and/or FDA-style regulatory pathways for one or more medical-grade AI applications, where applicable.

Evaluate future plans for subsidiaries Infinite Auctions and Real Game Used to operate under their own ticker symbols once MDCE achieves sustained, meaningful revenue growth.

The Company believes that its consumer-focused AI applications can help support operations and growth while it advances through the longer development, testing, and approval timelines required for medical-grade technologies.

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK:MDCE) is a technology company focused on developing AI-driven applications across consumer health, wellness, dietary, and medical markets. The Company also owns revenue-generating subsidiaries Infinite Auctions and Real Game Used.

Websites:
www.medicalcaretechnologies.com I www.mdcestock.com

Contact Information:
Address: MEDICAL CARE TECHNOLOGIES INC. 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204 Email: info@infiniteauctions.com, Phone: 480-645-0750

Subsidiaries Websites: www.infiniteauctions.com I www.realgameused.com

Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are based on current expectations and assumptions that are subject to risks, uncertainties, and factors that could cause actual results to differ materially. The Company undertakes no obligation to update or revise any forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medical-care-technologies-inc.-otc-pink-mdce-2026-annual-shareholder-1126184

© 2026 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.